Advertisement

Related Videos

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

Peter Clark, MA, MD, FRCP: A Payer Perspective

Opportunities to Optimize Cancer Policies Panel Discussion

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

S. Vincent Rajkumar, MD, on Cost-Effective Treatment of Multiple Myeloma

Advertisement

Advertisement




Jul
30
Today In Oncology
Rectal Cancer AI Identifies Patients Most Likely to Benefit From Irinotecan-Intensified Neoadjuvant Chemoradiotherapy
Beth Erickson, MD, FASTRO, Named ASTRO President-Elect
Monica Baskin Named Director of VCU Massey Comprehensive Cancer Center
Case Series Supports High-Dose Oral Vitamin D for Cancer Therapy–Related Skin Toxicities
MRI-Based T Staging Matches Traditional Clinical Staging in Localized Prostate Cancer
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo